Treatment of cirrhotic ascites.
D001201:Ascites / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D002319:Cardiovascular System / Q000503:physiopathology; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use; D004326:Drinking; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D008103:Liver Cirrhosis / Q000150:complications* / Q000503:physiopathology; D010536:Peritoneovenous Shunt / Q000009:adverse effects; D011170:Portasystemic Shunt, Surgical; D012964:Sodium / Q000008:administration & dosage; D013396:Suction; D014462:Ultrafiltration
D004232:Diuretics; D012964:Sodium